Headwinds Including Peak NII, Higher Beta Sensitivity, Slower NNA Forces Analyst To Double Downgrade Morgan Stanley – Morgan Stanley (NYSE:MS)
[ad_1] Wolfe Research analyst Steven Chubak downgraded Morgan Stanley MS from Outperform to Underperform with a $92 price target in a Wednesday note titled “See Better Wealth Alternatives at Current Valuation: Downgrade MS to Underperform.”…